Clinical trial
Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With…
NCT00011934 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00011934 |
|---|---|
| Title | Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia |
| Official title | Granulocyte-Macrophage Colony Stimulating Factor (Rhu-GM-CSF) and Autologous Bone Marrow Transplantation for Chronic Myeloid Leukemia |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Procedure |
| Interventions | recombinant interferon alfa, sargramostim, autologous bone marrow transplantation |
| Start date | May 1, 1998 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | May 4, 2004 |
| Last update posted | Apr 17, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: